U.S. Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

SEPTEMBER 20, 2012, (SEPTEMBER 14, 2012)
Date of Report (Date of earliest event Reported)

 

MESA LABORATORIES, INC.

(Exact Name of Small Business Issuer as Specified in its Charter)

 

Commission File Number: 0-11740

 

COLORADO

 

84-0872291

(State or other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification No.)

 

12100 WEST SIXTH AVENUE, LAKEWOOD,
COLORADO

 

80228

(Address of Principal Executive Offices)

 

(Zip Code)

 

Issuer’s telephone number, including area code: (303) 987-8000

 

Not Applicable.
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 5.07   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on September 14, 2012.  Of the 3,345,895 Shares entitled to vote, 2,917,175 were represented either in person or by proxy.  Seven Directors were elected to serve until the next Annual Meeting of Shareholders.  The appointment of Ehrhardt, Keefe, Steiner & Hottman, PC (EKS&H) as the Company’s independent public accountants for fiscal 2013 (the “Ratification of Auditors Proposal”) was approved.  The amendment to the Company’s articles of incorporation to increase the number of authorized shares of common stock from 8,000,000 to 25,000,000 (the “Amendment to the Articles of Incorporation Proposal”) was approved.

 

The seven directors elected were:

 

 

 

FOR

 

WITHHELD

 

BROKER NON-VOTES

 

Michael T. Brooks

 

2,393,140

 

26,389

 

497,646

 

H. Stuart Campbell

 

2,389,680

 

29,849

 

497,646

 

Robert V. Dwyer

 

2,386,278

 

33,251

 

497,646

 

Evan C. Guillemin

 

2,392,047

 

27,482

 

497,646

 

Luke R. Schmieder

 

2,088,627

 

330,902

 

497,646

 

John J. Sullivan, Ph.D.

 

2,399,117

 

20,412

 

497,646

 

David M. Kelly

 

2,390,946

 

28,583

 

497,646

 

 

The appointment of Ehrhardt, Keefe, Steiner & Hottman, PC (EKS&H) as the Company’s independent public accountants for fiscal 2013 (the “Ratification of Auditors Proposal”) was approved by the following vote:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-VOTES

 

 

 

 

 

 

 

 

 

2,896,088

 

16,484

 

4,603

 

 

 

 

The amendment to the Company’s articles of incorporation to increase the number of authorized shares of common stock from 8,000,000 to 25,000,000 (the “Amendment to the Articles of Incorporation Proposal”) was approved by the following vote:

 

FOR

 

AGAINST

 

ABSTAIN

 

BROKER NON-VOTES

 

 

 

 

 

 

 

 

 

2,070,695

 

843,630

 

1,719

 

1,131

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MESA LABORATORIES, INC.
(Issuer)

 

 

 

 

 

 

 

 

 

 

 

DATED: September 20, 2012

 

BY:

/s/ John J. Sullivan, Ph.D.

 

 

 

John J. Sullivan, Ph.D.

 

 

 

Chief Executive Officer,

 

 

 

President and Director

 

3